We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Nanotube Technique Repairs Bone Fractures

By Biotechdaily staff writers
Posted on 21 Jul 2005
Researchers have demonstrated for the first time that carbon nanotubes provide a suitable scaffold for bone tissue growth. More...


This new method could change the way clinicians treat broken bones, allowing them to simply inject a nanotube solution into a fracture to promote healing. The success of a bone graft depends on the capability of the scaffold to help in the natural healing process. Synthetic bone scaffolds have been produced from a wide assortment of materials, including peptide fibers or polymers, but they have various disadvantages, such as the potential for rejection in the body and low strength.

"Compared with these scaffolds, the high mechanical strength, excellent flexibility, and low density of carbon nanotubes make them ideal for the production of lightweight, high-strength materials such as bone,” commented Robert Haddon, Ph.D., a chemist at the University of California, Riverside (USA), and lead author of the article, which was published in the June 14, 2005, issue of the journal Chemistry of Materials.

Single-walled carbon nanotubes are a naturally occurring form of carbon, such as a diamond or graphite, where the atoms are arranged like a tube of chicken wire. They are among the strongest known compounds known to man. Bone tissue is a natural complex of collagen fibers and hydroxyapatite crystals. Dr. Haddon and his colleagues have shown for the first time that nanotubes can mimic the role of collagen as the scaffold for growth of hydroxyapatite in bone.

"This research is particularly notable in the sense that it points the way to a possible new direction for carbon nanotube applications, in the medical treatment of broken bones,” said Leonard Interrante, Ph.D., editor of Chemistry of Materials and a professor in the department of chemistry and chemical biology at Rensselaer Polytechnic Institute in (Troy, NY, USA). "This type of research is an example of how chemistry is being used everyday, world-wide, to develop materials that will improve peoples' lives.”

The investigators predict that nanotubes will increase the flexibility and strength of synthetic bone compounds, leading to a new kind of bone graft for breaks that may also be important in the treatment of osteoporosis. In a conventional bone graft, synthetic material or bone is shaped by the surgeon to fit in the affected region, according to Dr. Haddon. Screws or pins then hold the healthy bone to the implanted compound. Grafts offer a framework for bones to heal and regenerate, allowing bone cells to interlace into the porous structure of the implant, which supports the new tissue as it grows to connect broken bone sections.

The new method may soon provide clinicians with the capability to inject a nanotube solution into a bone fracture, and then wait for the new tissue to heal and grow. Simple single-walled carbon nanotubes are not enough, because the growth of hydroxyapatite crystals relies on the capability of the scaffold to draw in calcium ions and begin the crystallization process. Therefore, the scientists carefully designed nanotubes with several chemical groups attached. Some of these groups support the growth and orientation of hydroxyapatite crystals, allowing the scientists a level of control over their alignment, while other groups improve the biocompatibility of nanotubes by increasing their water solubility.

"Researchers today are realizing that mechanical mimicry of any material alone cannot succeed in duplicating the intricacies of the human body,” Dr. Haddon stated. "Interactions of these artificial materials with the systems of the human body are very important factors in determining clinical use.”

The study is still in its preliminary stages, but Dr. Haddon said he is encouraged by the study's findings. Before moving to clinical trials, he plans to assess the toxicity of these compounds and to assess their mechanical flexibility and strength in relation to commercially available bone mimics.




Related Links:
University of California, Riverside

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.